Sartans Market Trends 2025-2029: Regional Outlook and Sizing Analysis

 Drawing from trusted sources and expert analysis, this report helps businesses navigate the complex landscape of the sartans industry.





How Fast Is The Sartans Market Growing Towards 2025?

The sartans market size has grown steadily in recent years. It will grow from $21.36 billion in 2024 to $22.18 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to the growing adoption of sedentary lifestyles, increasing incidence of obesity, rising awareness about cardiovascular diseases, increasing healthcare expenditure, and rising demand for generic antihypertensive drugs.



The sartans market size is expected to see steady growth in the next few years. It will grow to $26.07 billion in 2029 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to increasing focus on combination therapies, rising investments in pharmaceutical R&D, growing demand in emerging markets, expanding healthcare infrastructure, and rising prevalence of lifestyle-related disorders. Major trends in the forecast period include advancements in drug delivery technologies, advanced manufacturing processes for APIs, the development of fixed-dose combination drugs, innovation in personalized hypertension treatment, and the development of novel sartan derivatives.



Get your free sample today:

Sartans Market Report 2025



Sartans Market Drivers And Opportunities

The rising prevalence of hypertension is expected to propel the growth of the sartans market going forward. Hypertension is a condition marked by persistently high blood pressure, which can raise the likelihood of heart disease, stroke, and other severe health complications. The growing incidence of hypertension is linked to diets rich in salt and processed foods, which lead to fluid retention and increased heart strain. Sartans treat hypertension by blocking angiotensin II, a hormone that narrows blood vessels. It helps relax and widen the vessels, lowering blood pressure and easing the heart's workload. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, there were 131,454 deaths primarily linked to high blood pressure in 2022, an increase from 124,508 deaths in 2021. Therefore, the rising prevalence of hypertension is driving the growth of the sartans market.



How Is The Sartans Market Segmented?

The sartans market covered in this report is segmented –



1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users



What Are The Key Trends And Market Opportunities In The Sartans Sector?

Major companies operating in the sartans market are focusing on developing advanced products, such as tablet-form sartans, to enhance treatment efficacy and patient adherence. Tablet-form sartans are oral medications that include sartan drugs, which block the effects of angiotensin II, promoting the relaxation of blood vessels and reducing blood pressure. For instance, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, received the US Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg). These tablets are marketed under the brand name Diovan. These tablets are prescribed to treat hypertension and heart failure and to improve survival post-heart-attack in adults and are also suitable for pediatric patients aged one year and older.



Major Companies Operating In The Sartans Market Are:

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.



View the full sartans market report here:

Sartans Market Report 2025



Regional Analysis: Opportunities And Challenges In The Sartans Market

North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.



Contact Us:



The Business Research Company



Market Research Reports



Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267



Email: info@tbrc.info





Follow Us On:



LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Future of the Antifungals Market: Insights, Developments, and Strategic Overview

Image
 Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the antifungals industry. Antifungals Market Valuation Forecast: What Will The Market Be Worth By 2025? The antifungals market size has grown strongly in recent years. It will grow from $27.16 billion in 2024 to $29.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education. The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, ...
Read more

Polybutylene Terephthalate (PBT) Market Analysis 2025 – Supporting High-Stakes Corporate Planning

Image
 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Polybutylene Terephthalate (PBT) industry. What is the projected value of the polybutylene terephthalate (pbt) market by 2029? The polybutylene terephthalate (PBT) market size has grown strongly in recent years. It will grow from $2.5 billion in 2024 to $2.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to adoption in new industries, global economic conditions, electrical vehicle adoption, consumer goods and textile applications, advancements in material properties. The polybutylene terephthalate (PBT) market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued focus on...
Read more

Zero Trust Security Market Report 2025 – Insights for Decision Makers and Market Strategists

Image
 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the zero trust security industry by 2029? The zero trust security market size has grown rapidly in recent years. It will grow from $38.45 billion in 2024 to $45.05 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to cyber threat landscape, legacy security challenges, digital transformation, remote workforce trend, data privacy concerns. The zero trust security market size is expected to see exponential growth in the next few years. It will grow to $99.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to threat intelligence integration, user-centric security approach, data volume growth, business co...
Read more